Long-Term Safety Study of Canagliflozin (TA-7284) in Combination With Insulin in Patients With Type 2 Diabetes Mellitus

NCT02622113 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

139

Enrollment

INDUSTRY

Sponsor class

Conditions

Type 2 Diabetes Mellitus

Interventions

DRUG: Canagliflozin (TA-7284)
DRUG: Insulin

Sponsor

Tanabe Pharma Corporation